Back
First Trust Nasdaq Oil & Gas ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
46
FTXN
First Trust Nasdaq Oil & Gas ETF
Last Price:
$27.39
Seasonality Move:
1.75%
Sell
34
MNPR
Monopar Therapeutics, Inc.
Last Price:
$69.11
Seasonality Move:
25.93%
Sell
46
First Trust Nasdaq Oil & Gas ETF (FTXN)
is a Sell
Is First Trust Nasdaq Oil & Gas ETF a Buy, Sell or Hold?
-
The current First Trust Nasdaq Oil & Gas ETF [FTXN] share price is $27.37. The Score for FTXN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
FTXN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FTXN Stock Price Chart
What is First Trust Nasdaq Oil & Gas ETF's stock price today?
-
The First Trust Nasdaq Oil & Gas ETF share price today is $27.37Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTXN is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $68.63Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.
FTXN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 40.93 | Sell |
| Chaikin Money Flow: | -13005 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.77 - 28.97) | Sell |
| Bollinger Bands (100): | (27.34 - 28.68) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.61 | Sell |
| Relative Strength Index (14 RSI): | 37.25 | Sell |
| Chaikin Money Flow: | 166161 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.18 - 85.74) | Sell |
| Bollinger Bands (100): | (45.57 - 89.21) | Buy |
FTXN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.08 | Sell |
| 20-day SMA: | 28.4 | Sell |
| 50-day SMA: | 27.89 | Sell |
| 200-day SMA: | 27.73 | Sell |
| 8-day EMA: | 27.9 | Sell |
| 20-day EMA: | 28.19 | Sell |
| 50-day EMA: | 27.64 | Sell |
| 200-day EMA: | 17.83 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.35 | Sell |
| 20-day SMA: | 78.65 | Sell |
| 50-day SMA: | 81.47 | Sell |
| 200-day SMA: | 52.32 | Buy |
| 8-day EMA: | 71.44 | Sell |
| 20-day EMA: | 75.9 | Sell |
| 50-day EMA: | 76.79 | Sell |
| 200-day EMA: | 56.68 | Buy |
First Trust Nasdaq Oil & Gas ETF Earnings Growth & FTXN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
First Trust Nasdaq Oil & Gas ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||